Showing results (991-1000 of 1,437) with videos related to

Sort By:
Pageof 144
Disease-A-Month : DM|May 1, 1995
Recognition, assessment, and treatment of anxiety in the critical care patientR C Bone, W R Hayden, R L Levine, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1983
Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigationsD J Meuten, G V Segre, C C Capen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1995
Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinomaE L Levine, A Renehan, R Gossiel, et al.
Bone Marrow Transplantation|October 28, 2003
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cellsA P Rapoport, B L Levine, A Badros, et al.
American Journal of Human Genetics|June 15, 2007
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarraysGo Yamamoto, Yasuhito Nannya, Motohiro Kato, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal menChristina Wang, Ronald Swerdloff, Mark Kipnes, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Virology|July 25, 2008
A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patientsJianqing J Yu, Te Lang Wu, Megan K Liszewski, et al.
Plos One|May 3, 2014
Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosisSerena De Vita, Rebekka K Schneider, Michael Garcia, et al.
Blood|August 5, 2004
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejectionPatricia A Taylor, Angela Panoskaltsis-Mortari, Jessica M Swedin, et al.
Pageof 144